Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gasperini

Showing results (391-400 of 981) with videos related to

Pageof 99
Sort By:
European Journal of Neurology|November 29, 2013
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalitiesC Fieschi, C Gasperini, G Ristori, et al.
Nucleic Acids Research|April 6, 2017
Identification and dynamic changes of RNAs isolated from RALY-containing ribonucleoprotein complexesAnnalisa Rossi, Albertomaria Moro, Toma Tebaldi, et al.
The Science of the Total Environment|March 15, 2017
The impact of the 1999 Mw 7.4 event in the İzmit Bay (Turkey) on anthropogenic contaminant (PCBs, PAHs and PBDEs) concentrations recorded in a deep sediment coreS Giuliani, L G Bellucci, M N Çağatay, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 21, 2024
Incidence and determinants of seizures in multiple sclerosis: a meta-analysis of randomised clinical trialsValeria Pozzilli, Shalom Haggiag, Massimiliano Di Filippo, et al.
Aging Clinical and Experimental Research|July 27, 2016
The earlier the better: health-related quality of life is inversely related to age of smoking cessation in older former Italian smokersBeatrice Gasperini, Pamela Barbadoro, Antonio Cherubini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 14, 1999
Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous resultsM P Sormani, P D Molyneux, C Gasperini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 5, 1998
Determinants of Gd-enhanced MRI response to IFN-beta-1a treatment in relapsing-remitting multiple sclerosisT Koudriavtseva, C Pozzilli, M Fiorelli, et al.
Biomedicines|September 28, 2024
Cellular Senescence: The Driving Force of Musculoskeletal DiseasesAngela Falvino, Beatrice Gasperini, Ida Cariati, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 17, 2013
Subsyndromal delirium and its determinants in elderly patients hospitalized for acute medical illnessGiovanni Zuliani, Francesco Bonetti, Stefania Magon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 7, 2002
MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1aC Gasperini, A Paolillo, E Giugni, et al.
Pageof 99

Showing results (391-400 of 981) with videos related to

Sort By:
Pageof 99
European Journal of Neurology|November 29, 2013
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalitiesC Fieschi, C Gasperini, G Ristori, et al.
Nucleic Acids Research|April 6, 2017
Identification and dynamic changes of RNAs isolated from RALY-containing ribonucleoprotein complexesAnnalisa Rossi, Albertomaria Moro, Toma Tebaldi, et al.
The Science of the Total Environment|March 15, 2017
The impact of the 1999 Mw 7.4 event in the İzmit Bay (Turkey) on anthropogenic contaminant (PCBs, PAHs and PBDEs) concentrations recorded in a deep sediment coreS Giuliani, L G Bellucci, M N Çağatay, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 21, 2024
Incidence and determinants of seizures in multiple sclerosis: a meta-analysis of randomised clinical trialsValeria Pozzilli, Shalom Haggiag, Massimiliano Di Filippo, et al.
Aging Clinical and Experimental Research|July 27, 2016
The earlier the better: health-related quality of life is inversely related to age of smoking cessation in older former Italian smokersBeatrice Gasperini, Pamela Barbadoro, Antonio Cherubini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 14, 1999
Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous resultsM P Sormani, P D Molyneux, C Gasperini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 5, 1998
Determinants of Gd-enhanced MRI response to IFN-beta-1a treatment in relapsing-remitting multiple sclerosisT Koudriavtseva, C Pozzilli, M Fiorelli, et al.
Biomedicines|September 28, 2024
Cellular Senescence: The Driving Force of Musculoskeletal DiseasesAngela Falvino, Beatrice Gasperini, Ida Cariati, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 17, 2013
Subsyndromal delirium and its determinants in elderly patients hospitalized for acute medical illnessGiovanni Zuliani, Francesco Bonetti, Stefania Magon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 7, 2002
MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1aC Gasperini, A Paolillo, E Giugni, et al.
Pageof 99